191 related articles for article (PubMed ID: 22127461)
1. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups.
Hapnes L; Willcox N; Oftedal BE; Owe JF; Gilhus NE; Meager A; Husebye ES; Wolff AS
J Clin Immunol; 2012 Apr; 32(2):230-7. PubMed ID: 22127461
[TBL] [Abstract][Full Text] [Related]
2. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
4. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).
Ströbel P; Murumägi A; Klein R; Luster M; Lahti M; Krohn K; Schalke B; Nix W; Gold R; Rieckmann P; Toyka K; Burek C; Rosenwald A; Müller-Hermelink HK; Pujoll-Borrell R; Meager A; Willcox N; Peterson P; Marx A
J Pathol; 2007 Apr; 211(5):563-571. PubMed ID: 17334980
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
[TBL] [Abstract][Full Text] [Related]
7. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis.
Meager A; Wadhwa M; Dilger P; Bird C; Thorpe R; Newsom-Davis J; Willcox N
Clin Exp Immunol; 2003 Apr; 132(1):128-36. PubMed ID: 12653847
[TBL] [Abstract][Full Text] [Related]
8. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.
Larosa MDP; Mackenzie R; Burne P; Garelli S; Barollo S; Masiero S; Rubin B; Chen S; Furmaniak J; Betterle C; Smith BR
Clin Chem Lab Med; 2017 Jun; 55(7):1003-1012. PubMed ID: 28099118
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I.
Oftedal BE; Wolff AS; Bratland E; Kämpe O; Perheentupa J; Myhre AG; Meager A; Purushothaman R; Ten S; Husebye ES
Clin Immunol; 2008 Oct; 129(1):163-9. PubMed ID: 18708298
[TBL] [Abstract][Full Text] [Related]
11. Hypothetical review: thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes.
Meager A; Peterson P; Willcox N
Clin Exp Immunol; 2008 Oct; 154(1):141-51. PubMed ID: 18727623
[TBL] [Abstract][Full Text] [Related]
12. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1.
Breivik L; Oftedal BE; Bøe Wolff AS; Bratland E; Orlova EM; Husebye ES
Clin Immunol; 2014 Jul; 153(1):220-7. PubMed ID: 24792136
[TBL] [Abstract][Full Text] [Related]
13. Anti-interferon auto-antibodies in autoimmune polyendocrinopathy syndrome type 1.
Levin M
PLoS Med; 2006 Jul; 3(7):e292. PubMed ID: 16756392
[TBL] [Abstract][Full Text] [Related]
14. Thymoma-associated myasthenia gravis: On the search for a pathogen signature.
Cufi P; Soussan P; Truffault F; Fetouchi R; Robinet M; Fadel E; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():29-35. PubMed ID: 24440286
[TBL] [Abstract][Full Text] [Related]
15. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.
Wolff AS; Sarkadi AK; Maródi L; Kärner J; Orlova E; Oftedal BE; Kisand K; Oláh E; Meloni A; Myhre AG; Husebye ES; Motaghedi R; Perheentupa J; Peterson P; Willcox N; Meager A
J Clin Immunol; 2013 Nov; 33(8):1341-8. PubMed ID: 24158785
[TBL] [Abstract][Full Text] [Related]
16. Thymus, thymoma and myasthenia gravis.
Fujii Y
Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
[TBL] [Abstract][Full Text] [Related]
17. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.
Meisel C; Akbil B; Meyer T; Lankes E; Corman VM; Staudacher O; Unterwalder N; Kölsch U; Drosten C; Mall MA; Kallinich T; Schnabel D; Goffinet C; von Bernuth H
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061776
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing antibodies against endogenous interferon in myasthenia gravis patients.
Bagnato F; Clemenzi A; Scagnolari C; Strizzi L; Di Pasquale A; Bellomi F; Di Marco P; Antonelli G; Antonini G
Eur Cytokine Netw; 2004; 15(1):24-9. PubMed ID: 15217749
[TBL] [Abstract][Full Text] [Related]
19. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
Smith CI; Aarli JA; Hammarström L; Persson MA
Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
[TBL] [Abstract][Full Text] [Related]
20. Multiplex Autoantibody Detection in Patients with Autoimmune Polyglandular Syndromes.
Savvateeva EN; Yukina MY; Nuralieva NF; Filippova MA; Gryadunov DA; Troshina EA
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
